Medana

Company Overview

Snapshot

Founded in January 2024 by Dr. Tal Patalon and Dr. Oren Elisha, Medana operates with 11–50 employees. The company has raised $2.28M across one funding round from one investor. In April 2025, Medana entered the Spanish market with its AI platform, aiming to transform healthcare across Europe.

Business overview

Medana is a Health Tech & Life Sciences company focused on bridging the gap between AI and real-world medical implementations. The company develops a foundational layer for AI-driven medicine, transforming static, fragmented data into a dynamic, proactive, and AI-ready infrastructure. Operating within the Digital Healthcare sector, Medana serves the healthcare industry, specifically providers, with its Artificial Intelligence technology.

Strategic signal

In April 2025, Medana expanded its operations into the Spanish market with its AI platform designed to transform healthcare across Europe. This strategic move signals the company's ambition for international growth and its commitment to leveraging AI to modernize healthcare systems on a broader scale, indicating potential for significant market penetration and impact.

Company Intelligence Q&A

When was Medana founded?

Medana was founded in January 2024 by Dr. Tal Patalon and Dr. Oren Elisha.

What is Medana's primary focus?

Medana focuses on creating a foundational layer for AI-driven medicine, transforming static, fragmented data into a dynamic, proactive, and AI-ready infrastructure to bridge the gap between AI and real-world medical implementations.

What significant market expansion did Medana undertake recently?

In April 2025, Medana entered the Spanish market with its AI platform, aiming to transform healthcare across Europe.

How much capital has Medana raised?

Medana has raised a total of $2.28M across one funding round.